Mpm Asset Management LLC Rhythm Pharmaceuticals, Inc. Transaction History

Mpm Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$20.25 - $39.49 $20.3 Million - $39.5 Million	-1,000,000 Reduced 52.38%	909,258 $19.3 Million
Q2 2020 Aug 12, 2020	SELL	$14.41 - $25.35 $6.49 Million - $11.4 Million	-450,205 Reduced 19.08%	1,909,258 $42.6 Million
Q1 2020 May 13, 2020	SELL	$13.16 - $22.9 $447,887 - $779,378	-34,034 Reduced 1.42%	2,359,463 $35.9 Million
Q4 2019 Feb 14, 2020	SELL	$19.53 - $25.5 $13.3 Million - $17.4 Million	-681,396 Reduced 22.16%	2,393,497 $55 Million
Q2 2018 Aug 13, 2018	BUY	$17.02 - $35.2 $6.44 Million - $13.3 Million	378,501 Added 14.04%	3,074,893 $96.1 Million
Q4 2017 Feb 02, 2018	BUY	$22.0 - $30.51 $59.3 Million - $82.3 Million	2,696,392	2,696,392 $78.4 Million

200

64.5M

834K

78.6K

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.21B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

Get notified when there are updates to the investment portfolio of Mpm Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Mpm Asset Management LLC with notifications on news.